Periodontal Disease and Alzheimer’s: Insights from a Systematic Literature Network Analysis Alice VillarS. PaladiniJ. Cossatis Review Open access 19 April 2024
Association between Resting Heart Rate and Machine Learning-Based Brain Age in Middle- and Older-Age J. WangH. HuangWeili Xu Original Research Open access 19 April 2024
Predicting Brain Amyloid Status Using the National Institute of Health Toolbox (NIHTB) for Assessment of Neurological and Behavioral Function Y. ChengE. HoHiroko H. Dodge Original Research 17 April 2024
Optimising Alzheimer’s Disease Diagnosis and Treatment: Assessing Cost-Utility of Integrating Blood Biomarkers in Clinical Practice for Disease-Modifying Treatment Sandar AyeR. HandelsL. Jönsson Original Research Open access 10 April 2024
Effectiveness of Resistance Exercise on Cognitive Function in Animal Models of Alzheimer Disease: A Systematic Review and Meta-Analysis F. O. de Andrade SantosA. A. PassosL. Teixeira-Machado Review Open access 10 April 2024
The Insulin Sensitizer KBP-336 Prevents Diabetes-Induced Cognitive decline in ZDF Rats Anna Thorsø LarsenK. E. MohamedK. Henriksen Original Research 10 April 2024
Hypnotics and Incident Dementia: A Risk Assessment Tomoyuki Kawada Letter to the Editor 06 April 2024
“Time Saved” Calculations to Improve Decision-Making in Progressive Disease Studies S. P. DicksonB. HaalandS. Hendrix Original Research Open access 02 April 2024 Pages: 529 - 536
Association between Cerebrospinal Fluid sTREM2 Levels and Depression: The Alzheimer’s Disease Neuroimaging Initiative Study Y. WangM. YeYiqiang Zhan Original Research 02 April 2024
Evaluating the Performance of Different Criteria in Diagnosing AD and Preclinical AD with the Bayesian Latent Class Model X. WangG. NiuQi Gao Original Research 02 April 2024
Interest in and Experience with Genetic Testing for Late-Onset Medical Conditions: Results from the National Poll on Healthy Aging S. J. FeldmanD. BlascoJ. Scott Roberts Original Research 02 April 2024
Economic Impact of Progression from Mild Cognitive Impairment to Alzheimer Disease in the United States Feride H. FrechG. LiH. Hampel Original Research Open access 02 April 2024
Visual Event-Related Potentials under External Emotional Stimuli as Early Signs for Mild Cognitive Impairment C. WangW. YuMing Tao Original Research 02 April 2024
The Effects of Different Exercise Interventions on Patients with Subjective Cognitive Decline: A Systematic Review and Network Meta-Analysis R. ChenB. ZhaoHongrui Zhan Original Research Open access 26 March 2024 Pages: 620 - 631
China Initiative for Multi-Domain Intervention (CHINA-IN-MUDI) to Prevent Cognitive Decline: Study Design and Progress S.-Y. LiX.-Y. XieYan Zeng Original Research 26 March 2024 Pages: 589 - 600
Alzheimer’s Disease Prediction Using Fly-Optimized Densely Connected Convolution Neural Networks Based on MRI Images R. SampathM. Baskar Original Research 26 March 2024
Association of Cognitive Reserve Indicator with Cognitive Decline and Structural Brain Differences in Middle and Older Age: Findings from the UK Biobank W. YangJ. WangWeili Xu Original Research Open access 19 March 2024 Pages: 739 - 748
Associations and Potential Multiple Mechanisms between Subjective Hearing Loss and Cognitive Impairment L. CuiY.-Y. TuQi-Hao Guo Original Research 19 March 2024 Pages: 649 - 660
The Multi-domain Lifestyle Intervention for Cognitive Impairment in Community-Dwelling Older Adults in Hangzhou (The Heritage Study): Study Design and Protocol Xin XuT. PangX. Xu Original Research 19 March 2024 Pages: 601 - 611
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials Haiyan LiuJ. LiDIAN-TU Study Team Original Research 19 March 2024 Pages: 558 - 566
At-home Administration of Gantenerumab by Care Partners to People with Early Alzheimer’s Disease: Feasibility, Safety and Pharmacodynamic Impact Frank G. BoessM. A. ScelsiGRADUATION Investigators and the gantenerumab study group Original Research 19 March 2024 Pages: 537 - 548
Performance of Fully-Automated High-Throughput Plasma Biomarker Assays for Alzheimer’s Disease in Amnestic Mild Cognitive Impairment Subjects G. M. GiuffrèDavide QuarantaC. Marra Brief Communication Open access 19 March 2024
Evaluation of Clinical Meaningfulness of Fortasyn Connect in Terms of “Time Saved” Samuel DicksonA. SolomonS. B. Hendrix Brief Communication Open access 13 March 2024
Sex Difference in the Association between Prior Fracture and Subsequent Risk of Incident Dementia: A Longitudinal Cohort Study D. GaoW. RongWuxiang Xie Original Research 13 March 2024
Fish and Shellfish Consumption, Cognitive Health and Mortality from Alzheimer’s Disease among US Adults Aged 60 and Older Hongbing Sun Original Research 11 March 2024 Pages: 632 - 638
Erratum to: Education as Risk Factor of Mild Cognitive Impairment: The Link to the Gut Microbiome Matthias KleeV. T. E. AhoNCER-PD Consortium Erratum 10 March 2024 Pages: 798 - 798
Prediction of Alzheimer’s Disease Based on 3D Genome Selected circRNA R. ChiK. LiYi Shi Original Research 06 March 2024
Association between Comorbidity Indices and Functional Autonomy in Individuals with Cognitive Impairment: A Systematic Review M. N. TemeddaA. Garnier-CrussardVirginie Dauphinot Review 06 March 2024
Value of Knowing: Health-Related Behavior Changes following Amyloid PET Results Disclosure in Mild Cognitive Impairment Y. WangD. RenJ. H. Lingler Original Research 06 March 2024
Examining Demographic Factors, Psychosocial Wellbeing and Cardiovascular Health in Subjective Cognitive Decline in the Brain Health Registry Cohort Rachana TankA. DiazR. L. Nosheny Original Research Open access 05 March 2024 Pages: 787 - 797
Global Burden of Alzheimer’s Disease and Other Dementias Attributed to High Fasting Plasma Glucose from 1990 to 2019 M. WangK. HuangZ.-J. Zheng Original Research 05 March 2024 Pages: 780 - 786
Usability of a Web-Based Registry for Preclinical Alzheimer’s Disease: Implications from a Cross-Sectional Online Survey Kenichiro SatoY. NiimiTakeshi Iwatsubo Original Research 05 March 2024 Pages: 661 - 671
Magnetic Resonance Imaging-Negative Cerebral Amyloid Angiopathy: Cerebrospinal Fluid Amyloid-β42 over Amyloid Positron Emission Tomography J.-M. PyunM. J. KangAlzheimer’s Disease Neuroimaging Initiative Original Research 05 March 2024
Female Reproductive Factors and Risk of Mild Cognitive Impairment and Dementia: The HUNT Study Yehani WedatilakeC. MyrstadG. Selbæk Original Research Open access 05 March 2024
Sustainable Participation in Community Health Programs to Promote a Healthy Lifestyle and Prevent and Protect against Dementia among Rural Taiwanese Middle-Aged and Older Adults L. ChangShu-Chuan ChenM.-C. Chen Original Research 21 February 2024 Pages: 612 - 619
Critical Values of Daily Sedentary Time and Its Longitudinal Association with Mild Cognitive Impairment Considering APOE ε4: A Prospective Cohort Study H. DuanX. HeGuowei Huang Original Research 21 February 2024 Pages: 582 - 588
“Back to Braak”: Role of Nucleus Reuniens and Subcortical Pathways in Alzheimer’s Disease Progression S. CensiC. SestieriAlzheimer’s Disease Neuroimaging Initiative Original Research Open access 21 February 2024
Serum Tau-A and Tau-C Levels and Their Association with Cognitive Impairment and Dementia Progression in a Memory Clinic Derived Cohort Tobias Melton AxelsenP. HøghA. H. Simonsen Original Research 19 February 2024 Pages: 730 - 738
Longitudinal Impacts of Precision Greenness on Alzheimer’s Disease S. C. BrownW. W. AitkenJ. Szapocznik Original Research Open access 16 February 2024 Pages: 710 - 720
Anti-Hypertensive Drugs Moderate the Relationship of Blood Pressure with Alzheimer’s Pathologies and Neurodegenerative Markers in Non-Demented Hypertensive Older Adults Y. GuoC.-C. TanAlzheimer’s Disease Neuroimaging Initiative Original Research 15 February 2024 Pages: 672 - 683
Who Benefited Most from the Internet-Based Conversational Engagement RCT (I-CONECT)? Application of the Personalized Medicine Approach to a Behavioral Intervention Study Chao-Yi WuK. YuH. H. Dodge Original Research Open access 15 February 2024 Pages: 639 - 648
Anti-Amyloid Therapies for Alzheimer’s Disease: An Alzheimer Europe Position Paper and Call to Action Angela C. BradshawJ. GeorgesAlzheimer Europe Board Special Article Open access 10 February 2024 Pages: 265 - 273
Phase 2A Learnings Incorporated into RewinD-LB, a Phase 2B Clinical Trial of Neflamapimod in Dementia with Lewy Bodies N. D. PrinsW. de HaanJohn J. Alam Original Research Open access 09 February 2024 Pages: 549 - 557
24-Hour Blood Pressure Variability Via Ambulatory Monitoring and Risk for Probable Dementia in the SPRINT Trial I. J. SibleDaniel A. Nation Original Research Open access 07 February 2024 Pages: 684 - 692
Estimated Investment Need to Increase England’s Capacity to Diagnose Eligibility for an Alzheimer’s Treatment to G7 Average Capacity Levels Soeren MattkeZ. ShiL. Lanman Original Research Open access 07 February 2024
Multiomics Blood-Based Biomarkers Predict Alzheimer’s Predementia with High Specificity in a Multicentric Cohort Study B. SouchetA. MichaïlJérôme Braudeau Original Research Open access 06 February 2024 Pages: 567 - 581
A Pragmatic, Investigator-Driven Process for Disclosure of Amyloid PET Scan Results to ADNI-4 Research Participants C. M. EricksonJ. KarlawishEmily A. Largent Brief Communication 06 February 2024 Pages: 294 - 302
Fruit Intake and Alzheimer’s Disease: Results from Mendelian Randomization Wan-Zhe LiaoX.-F. ZhuXu-Guang Guo Brief Communication 31 January 2024 Pages: 445 - 452
Mendelian Randomization Analysis Reveals Causal Factors behind Alzheimer’s Disease Risk: Evidence, Opportunities, and Challenges X. FengL. ZhangLin Yang Review 30 January 2024 Pages: 749 - 758
Polygenic Risk Score Reveals Genetic Heterogeneity of Alzheimer’s Disease between the Chinese and European Populations F. LiS. XieJianping Jia Original Research 30 January 2024 Pages: 701 - 709
